knowledge logo

BEI Resources Knowledge Base


Search Our Knowledge Base

The Knowledge Base is an informational database assembled by our Support Specialists and Scientific Staff which provides additional knowledge about the BEI Resources program and reagents through questions and answers. In order to use the Knowledge Base, enter a keyword or phrase that best describes the information of interest. More >>
   

Showing 1 to 1 of 1 Results
Does BEI Resources accept hybridoma deposits?

Yes, BEI Resources does accept hybridoma desposits. BEI Resources does not distribute the hybridoma cell stocks but rather the culture supernatants or purified monoclonal antibodies to registrants.

Author: BEI Resources
0 Comments
Rating:
Updated on: 12/4/2013 10:18:27 AM
Showing 1 to 1 of 1 Results



Sorry, there are no articles found for the search criteria at this time.


The following is a list of published abstracts and papers where the work was either facilitated, or directly supported, by the BEI Resources Program.


Showing 1 to 5 of 318 Results12345678910...>>
Tenggara, M.K., et al., Frequency-potency analysis of IgG+ memory B cells delineates neutralizing antibody responses at single-cell resolution. Cell Reports, 2024. 43(3).
Author: BEI Resources
Updated on: 4/10/2024 11:08:35 AM
Spatola, M., et al., Distinctive antibody responses to Mycobacterium tuberculosis in pulmonary and brain infection. Brain, 2024: p. awae066.
Author: BEI Resources
Updated on: 4/10/2024 11:06:44 AM
Mannar, D., et al., Altered receptor binding, antibody evasion and retention of T cell recognition by the SARS-CoV-2 XBB. 1.5 spike protein. Nature Communications, 2024. 15(1): p. 1854.
Author: BEI Resources
Updated on: 4/9/2024 3:31:47 PM
Khera, H., et al., Nano-Differential Scanning Fluorimetry as a tool for assessment of refolded antibody fragments: a case study for anti-Pfs25 single-chain antibodies. Biochemical Engineering Journal, 2024: p. 109287.
Author: BEI Resources
Updated on: 4/9/2024 3:01:45 PM
Abbad, A., et al., SARS-CoV-2 BA. 1 and BA. 2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ. 1.1 or XBB. 1.5. Cell Reports Medicine, 2024. 5(3).
Author: BEI Resources
Updated on: 4/9/2024 2:02:31 PM
Showing 1 to 5 of 318 Results12345678910...>>
The following is a list of published abstracts and papers where the work was either facilitated, or directly supported, by the NIH HIV Reagent Program.



Showing 1 to 5 of 59 Results12345678910...>>

Beckford-Vera, D.R., et al., First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody. Nature Communications, 2022. 13(1): p. 1219.

Author: HIV
Updated on: 9/2/2022 2:33:35 PM

Cooper, L., J.G. Achi, and L. Rong, Comparative analyses of small molecule and antibody inhibition on glycoprotein‐mediated entry of Měngla virus with other filoviruses. Journal of Medical Virology, 2022.

Author: HIV
Updated on: 9/6/2022 9:16:26 AM

DeCotes, D., et al., Highly mutated monoclonal antibody 3F2 targets a conformational and strain-restricted epitope in human immunodeficiency virus gp41 with significant antibody-dependent cell cytotoxicity. Archives of Virology, 2022: p. 1-9.

Author: HIV
Updated on: 9/6/2022 9:30:29 AM

Evans, J.P., et al., Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection. Science translational medicine, 2022. 14(637): p. eabn8057.

Author: HIV
Updated on: 9/6/2022 9:48:35 AM

Heydarchi, B., et al., Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induced CD4 binding site bovine antibody. Cell Reports Medicine, 2022. 3(5): p. 100635.

Author: HIV
Updated on: 9/12/2022 2:27:52 PM
Showing 1 to 5 of 59 Results12345678910...>>